IMI International Medical Innovations to Present at the American Stock Exchange Annual Online Healthcare & Biotech Investor Conference TORONTO, June 21 /PRNewswire-FirstCall/ -- IMI International Medical Innovations Inc. (Amex: IME; TSX: IMI), a world leader in predictive medicine, today announced that it will be presenting at the American Stock Exchange Annual Online Healthcare & Biotech Investor Conference on Tuesday, June 22, 2004 at 10 a.m. (ET). The webcast may be accessed at http://www.vcall.com/CEPage.asp?ID=88403. The presentation will also be archived at http://www.vcallconferences.com/ and at http://www.imimedical.com/. Minimum requirements to listen to broadcast: Windows Media Player software, downloadable free from http://microsoft.com/windows/windowsmedia/EN/default.asp and at least a 28.8Kbps connection to the Internet. If you experience problems listening to the broadcast, please email . About IMI IMI is a world leader in predictive medicine, dedicated to developing rapid, non-invasive tests for the early detection of life-threatening diseases. IMI's cardiovascular products, which are branded as PREVU(x) Coronary Heart Disease Predictor, will be marketed and distributed worldwide by McNeil Consumer Healthcare (J&J). The company's cancer tests include ColorectAlert(TM), LungAlert(TM) and a breast cancer test. IMI's head office is located in Toronto, and its research and product development facility is at McMaster University in Hamilton, Ontario. For additional information, please visit http://www.imimedical.com/. DATASOURCE: IMI International Medical Innovations Inc. CONTACT: Sarah Borg-Olivier, Director, Communications, IMI International Medical Innovations Inc., T: (416) 222-3449,

Copyright